我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

灯盏乙素、灯盏乙素苷元及四乙酰灯盏乙素苷元联合三氧化二砷对乳腺癌细胞的增殖抑制作用研究(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2016年06期
页码:
17-20
栏目:
实验研究
出版日期:
2016-12-10

文章信息/Info

Title:
Study of Scutellarin,Scutellarein and Tetraacetyl Scutellarein Combined with Arsenic Trioxideon Breast Cancer Cell Proliferation Inhibition
作者:
倪广惠12何越峰3
1. 云南中医学院中药学院,云南 昆明 650500;2. 云南省民族特色养生理论与健康产品工程实验室,云南 昆明 650500;3. 昆明医科大学公共卫生学院,云南 昆明 650500
Author(s):
NI Guanghui12 HE Yuefeng3
1. College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;2. Engineering Laboratory for National Healthcare Theories and Products of Yunnan Province, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;3. School of Public Health, Kunming Medical University, Kunming 650500, China
关键词:
灯盏乙素 灯盏乙素苷元 四乙酰灯盏乙素苷元 三氧化二砷 乳腺癌
Keywords:
scutellarin scutellarein tetraacetyl scutellarein arsenic trioxide breast cancer
分类号:
R285.5
DOI:
10.19288/j.cnki.issn.1000-2723.2016.06.005
文献标识码:
A
摘要:
目的 探讨灯盏乙素及其衍生物和三氧化二砷单独及联合用药对乳腺癌细胞的作用。方法 将体外培养的乳腺癌MDA-MB-231细胞分成对照组和用药组,每组设6个复孔。用药组为灯盏乙素及其衍生物(灯盏乙素苷元与四乙酰灯盏乙素苷元)单独用药,以及与5μM三氧化二砷一起联合用药。用MTT法测试它们对乳腺癌MDA-MB-231细胞的抑制作用。结果 灯盏乙素单独用药时,剂量为10μmol·L-1、50μmol·L-1、100μmol·L-1时,对MDA-MB-231细胞的抑制率分别为(0.01±5.56)%、(18.18±3.46)%、(35.72±5.27)%;灯盏乙素与5μM As2O3联合用药时,抑制率分别为(13.55±3.54)%、(32.6±5.09)%、(35.29±6.96)%。灯盏乙素苷元单独用药时,剂量为10μmol·L-1、50μmol·L-1、100μmol·L-1时,对MDA-MB-231细胞的抑制率分别为(1.13±5.46)%、(1.68±6.55)%、(3.86±5.51)%;与5μM As2O3联合用药时,抑制率分别为(17.90±2.41)%、(28.13±4.63)%、(34.94±2.41)%。四乙酰灯盏乙素苷元单独用药时,剂量为1μmol·L-1、5μmol·L-1、10μmol·L-1时,对MDA-MB-231细胞的抑制率分别为(0.76±5.07)%、(1.34±4.07)%、(-0.40±7.59)%;与5μM As2O3联合用药时,抑制率分别为(16.52±5.91)%、(17.25±3.89)%、(13.62±7.24)%. 结论 单独用药时,灯盏乙素对MDA-MB-231细胞的抑制作用大于灯盏乙素苷元及四乙酰灯盏乙素,糖基的去除和乙酰化使其作用减弱;与三氧化二砷联用时,灯盏乙素及灯盏乙素苷元对细胞有显著的抑制作用。其中,灯盏乙素苷元单独使用无抑制活性,却能显著增强三氧化二砷对细胞的抑制作用。灯盏乙素苷元与三氧化二砷联合用药具有治疗乳腺癌的应用前景。
Abstract:
Objective To investigate the effects of scutellarin and its derivatives on breast cancer cells and the synergistic anti-tumor effects of scutellarin and its derivatives combined with arsenic trioxide. Methods Human breast cancer MDA-MB-23 cells were cultured in vitro and divided into control and test groups. Every group was set 6 wells. Test groups were treated with scutellarin and its derivatives alone and combined with 5μM arsenic trioxide. One of the derivatives of scutellarin is scutellarein, which is the glycone of scutellarin. Scutellarein is also the main metabolism product of scutellarin in vivo. The other derivatives of scutellarin is tetraacetyl scutellarein, which we synthesized to improve the low bioavailability of scutellarin. Inhibition of MDA-MB-23 cells proliferation was tested by MTS assays. Results Scutellarin alone inhibited cell proliferation in a dose-dependent manner, when scutellarein and tetraacetylscutellarein showed slight inhibition effect. It indicated that the glucuronic acid moiety of scutellarin played an important part in cell proliferation inhibition. Both scutellarin and scutellarein combined with arsenic trioxide exerted synergistic effects on proliferation inhibition in MDA-MB-231 cells in dose-dependent manners. Particularly, scutellarein did not inhibit cell proliferation alone but significantly enhance the proliferation inhibition of arsenic trioxide on MDA-MB-231 cells. Conclusion The combination of scutellarein and arsenic trioxide inhibits breast cancer development more effectively than each drug alone.

参考文献/References

[1] 蔡丽珠,冯春,罗珊珊,等. HPLC法测定无糖型灯盏细辛合剂中野黄芩苷含量[J]. 云南中医学院学报,2014,37(6):5-8.
[2] 石美娜,杨为民,刘璇. 灯盏花乙素药理作用研究进展[J]. 昆明医科大学学报,2013,34(9):151-154.
[3] 王银辉,耿玲,李辉. 灯盏乙素抗大鼠肝纤维化作用的研究[J]. 中国中药杂志,2015,40(10):1999-2003.
[4] 石森林,徐莲英,毛展凯,等. 灯盏花素的理化性质及其稳定性影响因素研究[J]. 中国中药杂志,2009,34(7):843-847.
[5] 刘建明,熊玉卿. 灯盏乙素及其苷元药代动力学特征的研究进展[J]. 中国中药杂志,2009,34(24):3165-3168.
[6] Wu YX,Sato E,Kimura W,et al. Baicalin and scutellarin are proteasome inhibitors that specifically target chymotrypsin-like catalytic activity[J]. Phytother Res,2013,27(9):1362-1367.
[7] Cheng CY,Hu CC,Yang HJ,et al. Inhibitory effects of scutellarein on proliferation of human lung cancer A549 cells through ERK and NFκB mediated by the EGFR pathway[J]. Chin J Physiol,2014,57(4):182-187.
[8] Feng YZ,Zhang SS,Tu J,et al. Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells[J]. Leuk Lymphoma,2012,53(12):2456-2464.
[9] Hsiao WL,Liu L. The role of traditional Chinese herbal medicines in cancer therapy–from TCM theory to mechanistic insights[J].Planta Med,2010,76(11):1118-1131.
[10] Li H,Huang D,Gao Z,et al. Scutellarin inhibits cell migration by regulating production of alphavbeta6 integrin and E-cadherin in human tongue cancer cells[J]. Oncol Rep,2010,24(5):1153-1160.
[11] Chan JY,Tan BK,Lee SC.Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation[J]. Anticancer Res,2009,29(8):3043-3047.
[12] Xu H,Zhang S. Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway[J]. Phytother Res,2013,27(10):1524-1528.
[13] Li J,Wang Y,Lei JC,et al. Sensitisation of ovarian cancer cells to cisplatin by flavonoids from scutellaria barbata[J]. Nat Prod Res,2014,28(10):683-689.
[14] 张颖,李俊玫,秦博文,等. 野黄芩苷对人舌鳞癌Tca8113细胞凋亡及caspase-8表达的影响[J]. 天津医药,2015,43(3):237-240.
[15] Du J,Zhou N,Liu H,et al. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer[J]. Plos One,2012,7(4):e35957.
[16] 石莹,胡博,郭俣,等. 三氧化二砷抑制小鼠乳腺癌细胞MA-891生长作用及其对端粒酶活性的影响[J]. 中国中药杂志,2012,37(5):637-642.

备注/Memo

备注/Memo:
* 基金项目: 云南省应用基础研究-中医联合专项(2015FB205-029);云南公共卫生与疾病防控协同创新中心项目 (2016YNPHXT15) 收稿日期: 2016 - 11 - 02 作者简介: 倪广惠(1983-),女,博士,讲师,主要从事天然产物的有机合成及活性研究。△通信作者:何越峰,E-mail:heyuefeng@kmmu.edu.cn
更新日期/Last Update: 2016-11-20